Pharmaceuticals
Pharmaceuticals
88% of life sciences survey respondents said that using real world data (RWD) across R&D would enhance decision-making and 68% felt that improved digitisation would improve patient experience in clinical trials
Examples of questions we answer:
- What does search behaviour tell us about patient and professional needs (e.g. for information or education) and how can this inform R&D?
- What are the policy and regulatory hurdles to building digital engagement and how can they be managed in terms of compliance?
- How can patient data be leveraged for competitive advantage and can we map patient journeys to better understand the various touchpoints across the treatment process?
